Cencora | COR

Stock Price
292.50
Daily Change
-0.20 -0.07%
Monthly
3.07%
Yearly
24.33%
Q3 Forecast
290.07

Peers Price Chg Day Year Date
Supermax Corporation Bhd 0.47 0 0% -31.22% Sep/04
Ambu A/S 96.80 1.75 1.84% -24.76% Sep/05
Amplifon 15.28 0.19 1.23% -45.41% Sep/05
Apollo Hospitals Enterprise Ltd 7,804.50 -95.50 -1.21% 13.00% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Brookdale Senior Living 7.69 0.04 0.52% 14.26% Sep/05
Cencora 292.50 -0.20 -0.07% 24.33% Sep/05
Convatec Group 239.00 0 0% 2.75% Sep/05
Diasorin 82.34 -0.22 -0.27% -18.60% Sep/05
Encompass Health 125.58 1.10 0.88% 37.01% Sep/05
Enovis 32.13 0.58 1.84% -26.04% Sep/05
GE HealthCare Technologies 75.73 1.61 2.17% -11.00% Sep/05
Gulf Medical Proj 2.27 0.12 5.58% 32.75% Sep/04
Med Life 7.48 0 0% 31.00% Sep/05
Oriola-kd 1.17 0.01 0.51% 26.92% Sep/05
Rede D'Or Sao Luiz 39.30 0.26 0.67% 17.84% Sep/05
Siemens Healthineers 47.24 0.10 0.21% -5.71% Sep/06
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
Sonova Holding 239.50 1.90 0.80% -19.82% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Cencora Inc traded at $292.50 this Friday September 5th, decreasing $0.20 or 0.07 percent since the previous trading session. Looking back, over the last four weeks, Cencora lost 3.07 percent. Over the last 12 months, its price rose by 24.33 percent. Looking ahead, we forecast Cencora Inc to be priced at 290.07 by the end of this quarter and at 282.91 in one year, according to Trading Economics global macro models projections and analysts expectations.

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.